Starling Oncology, Inc.
STLNReported to SECin USCIK 0001799191Filings at SEC EDGAR
STLN is one of 3 listed share classes under this CIK; the filings below cover all of them.
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 20. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Hively Brad— | Open-market sell | $1,946,310298,853 shares | Aug 24, 2026 | Hively Brad | $1,946,310 | Open-market sell | 298,853 | Aug 24, 2026 |
| Chernett Jorey— | Open-market sell | $624100 shares | Aug 17, 2026 | Chernett Jorey | $624 | Open-market sell | 100 | Aug 17, 2026 |
| Chernett Jorey— | Open-market buy | $78,48012,000 shares | Aug 17, 2026 | Chernett Jorey | $78,480 | Open-market buy | 12,000 | Aug 17, 2026 |
| Kaushal Mohit— | Award | nothing paid33,133 shares | Jul 29, 2026 | Kaushal Mohit | nothing paid | Award | 33,133 | Jul 29, 2026 |
| McGeorge Anne— | Award | nothing paid41,165 shares | Jul 29, 2026 | McGeorge Anne | nothing paid | Award | 41,165 | Jul 29, 2026 |